Patients are helping researchers, including those at McMaster University, clarify the essential aspects of assessing the value of gene therapy in hemophilia.
An international team involving dozens of stakeholders from patients and policy makers to payers and government agencies are getting together to set how gene therapies in hemophilia should be measured for effectiveness.
McMaster logo
McMaster logo
